COX-2-selective nonsteroidal anti-inflammatory drugs (NSAIDs) appear to be a safer option than their nonselective counterparts among patients with atrial fibrillation (AF) who are taking a direct oral ...
Pharmacokinetic and pharmacodynamic results of a 4-hr IV administration phase I study with EPC2407, a novel vascular disrupting agent This is an ASCO Meeting Abstract from the 2009 ASCO Annual Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results